Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in